Figure 5
Figure 5. CMV-seropositive patients have an altered CD4+ T-cell repertoire. (A) CD28−CD57+CD4+ T cells are present almost exclusively in CMV-seropositive patients. PBMC were stained with monoclonal antibodies against CD8, CD28, and CD57, and the relative expression of CD28 and CD57 was determined on the CD8+ T-cell populations of CMV-seropositive and seronegative patients. Significant differences in the number of CD57+, CD28− and CD57+CD28− populations were observed between the 2 groups. (B) The phenotype of the CD4+ T-cell repertoire is markedly altered in CMV-seropositive patients (n = 12) compared with an age-matched CMV-seropositive control group (n = 10). PBMC were stained with monoclonal antibodies against CD4, CD27, CD28, CD57, CD45RA, CD45RO, and CCR7, and the relative expression of each marker was determined in the CD4+ T-cell population. Significant differences were observed between the 2 groups.

CMV-seropositive patients have an altered CD4+ T-cell repertoire. (A) CD28CD57+CD4+ T cells are present almost exclusively in CMV-seropositive patients. PBMC were stained with monoclonal antibodies against CD8, CD28, and CD57, and the relative expression of CD28 and CD57 was determined on the CD8+ T-cell populations of CMV-seropositive and seronegative patients. Significant differences in the number of CD57+, CD28 and CD57+CD28 populations were observed between the 2 groups. (B) The phenotype of the CD4+ T-cell repertoire is markedly altered in CMV-seropositive patients (n = 12) compared with an age-matched CMV-seropositive control group (n = 10). PBMC were stained with monoclonal antibodies against CD4, CD27, CD28, CD57, CD45RA, CD45RO, and CCR7, and the relative expression of each marker was determined in the CD4+ T-cell population. Significant differences were observed between the 2 groups.

Close Modal

or Create an Account

Close Modal
Close Modal